Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:856-860

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Maat, M. P.M.
Right arrow Articles by Kluft, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Maat, M. P.M.
Right arrow Articles by Kluft, C.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:856-860.)
© 1995 American Heart Association, Inc.


Articles

Gender-Related Association Between ß-Fibrinogen Genotype and Plasma Fibrinogen Levels and Linkage Disequilibrium at the Fibrinogen Locus in Greenland Inuit

Moniek P.M. de Maat; Peter de Knijff; Fiona R. Green; Angela E. Thomas; Jørgen Jespersen; Cornelis Kluft

From the Gaubius Laboratory TNO-PG, Leiden, the Netherlands (M.P.M. de M., P. de K., C.K.); the Institute for Thrombosis Research, South Jutland University Centre, Esbjerg, Denmark (M.P.M. de M., J.J.); and The Rayne Institute, Department of Medicine, University College London Medical School, London, UK (F.R.G., A.E.T.).

Correspondence to M.P.M. de Maat, Gaubius Laboratory TNO-PG, PO Box 2215, 2301 CE Leiden, Netherlands.

Abstract Elevated plasma fibrinogen levels represent an increased risk for cardiovascular disease, but the mechanism explaining this association is still not clear. Genetic differences may play a role, because it has been shown that individuals who carry the rare alleles of polymorphisms in the genes for the Bß-chain (Bcl I and G/A-455) and the A{alpha}-chain (Taq I) of fibrinogen have higher plasma fibrinogen levels and that patients with peripheral arterial disease have a higher frequency of the rare allele of the Bcl I polymorphism than do healthy control subjects. We studied the Greenland Inuit, a population with a low incidence of ischemic heart disease; polymorphisms of the fibrinogen gene; and their association with plasma fibrinogen level. The group studied had a small age range (30 to 34 years), 97% were smokers, 62 were men, and 71 were women. We observed that in the Inuit, frequencies of the rare alleles of the ß gene and of the common alleles of the {alpha} gene polymorphisms were lower than those published for other populations (all Caucasian). Accordingly, in the Inuit, these distribution patterns give a higher frequency of alleles that are associated with lower plasma fibrinogen levels. We further observed comparable linkage disequilibrium between {alpha} and ß gene polymorphisms in Caucasian populations. In Inuit men the rare allele of the Bcl I and G/A-455 fibrinogen polymorphisms was associated with plasma fibrinogen level comparable with the association described in Caucasian populations. In women, however, we did not find a significant association, supporting the desirability of separate data analysis for men and women of the influence of genetic factors on atherosclerotic disease. In conclusion, in the Inuit the association of fibrinogen polymorphisms with fibrinogen levels is comparable with that in Caucasians, but the genes that are associated with lower fibrinogen levels are more frequent in the Inuit than in Caucasians.


Key Words: fibrinogen • Inuit • cardiovascular risk indicators • DNA polymorphism




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
K. Kain, J. M. Blaxill, A. J. Catto, P. J. Grant, and A. M. Carter
Increased Fibrinogen Levels among South Asians versus Whites in the United Kingdom Are Not Explained by Common Polymorphisms
Am. J. Epidemiol., July 15, 2002; 156(2): 174 - 179.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. B. Braunstein, D. W. Kershner, P. Bray, G. Gerstenblith, S. P. Schulman, W. S. Post, and R. S. Blumenthal
Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women
Chest, March 1, 2002; 121(3): 906 - 920.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Iacoviello, M. Vischetti, F. Zito, and M. Benedetta Donati
Genes Encoding Fibrinogen and Cardiovascular Risk
Hypertension, November 1, 2001; 38(5): 1199 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
Y Liu, N Saha, C K Heng, S Hong, and P S Low
Fibrinogen genotypes ({alpha} and {beta}) are associated with plasma fibrinogen levels in Chinese
J. Med. Genet., September 1, 2001; 38(9): e31 - 31.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M. van ’t Hooft, S. J. F. von Bahr, A. Silveira, A. Iliadou, P. Eriksson, and A. Hamsten
Two Common, Functional Polymorphisms in the Promoter Region of the {beta}-Fibrinogen Gene Contribute to Regulation of Plasma Fibrinogen Concentration
Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 3063 - 3070.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Maresca, A. Di Blasio, R. Marchioli, and G. Di Minno
Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update
Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1368 - 1377.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. T. Brown and G. M. Fuller
Detection of a Complex That Associates With the Bbeta Fibrinogen G-455-A Polymorphism
Blood, November 1, 1998; 92(9): 3286 - 3293.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. S. Pankow, A. R. Folsom, M. A. Province, D. C. Rao, R. R. Williams, J. Eckfeldt, and T. A. Sellers
Segregation Analysis of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in the NHLBI Family Heart Study
Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1559 - 1567.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Zito, A. Di Castelnuovo, C. Amore, A. D'Orazio, M. B. Donati, and L. Iacoviello
Bcl I Polymorphism in the Fibrinogen ß-Chain Gene Is Associated With the Risk of Familial Myocardial Infarction by Increasing Plasma Fibrinogen Levels : A Case-Control Study in a Sample of GISSI-2 Patients
Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3489 - 3494.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Kessler, C. Spitzer, D. Stauske, S. Mende, J. Stadlmuller, R. Walther, and R. Rettig
The Apolipoprotein E and ß-Fibrinogen G/A-455 Gene Polymorphisms Are Associated With Ischemic Stroke Involving Large-Vessel Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2880 - 2884.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. P.M. de Maat, F. Green, P. de Knijff, J. Jespersen, and C. Kluft
Factor VII Polymorphisms in Populations With Different Risks of Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1918 - 1923.
[Abstract] [Full Text]


Home page
CirculationHome page
A. M. Carter, N. Ossei-Gerning, I. J. Wilson, and P. J. Grant
Association of the Platelet PlA Polymorphism of Glycoprotein IIb/IIIa and the Fibrinogen Bß 448 Polymorphism With Myocardial Infarction and Extent of Coronary Artery Disease
Circulation, September 2, 1997; 96(5): 1424 - 1431.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. M. Carter, A. J. Catto, J. M. Bamford, and P. J. Grant
Gender-Specific Associations of the Fibrinogen Bß 448 Polymorphism, Fibrinogen Levels, and Acute Cerebrovascular Disease
Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 589 - 594.
[Abstract] [Full Text]